$heff's $tation of $tocks & $olid DD

[BioHunter]

$MTNB

I was offline remote part of S America last week. Looks like I missed a lot of fun in bio. I just went through MTNB call this morning and as usual the Q&A was interesting.

It's disappointing NIH had only two patients with data. After seeing what those two individuals had to do with flight from across the country several times to participate it's somewhat understandable. Basically they had to fly to Baltimore multiple times to participate. One patient from Minnesota the other I think was Arizona.

The data was important proof of concept. Basically will the immune system transport the cochleate drug wrapper to site of infection. That appears to be confirmed. P2 trials normally answer some question but often create new question and that appears to be the case here.

The VVC data in a few weeks becomes an important catalyst. This is a company sponsored trial and will have over 70 patients. If positive MTNB will be off to the races. But it's hard to handicap here.

I sold 1/2 of my position today with part stopped out last week at current levels. Small loss on these shares but still a big gain on the year from the trade 1.60 to 3.80.


-BioHunter